256 related articles for article (PubMed ID: 34406860)
1. The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.
Kanda T; Horie M; Komatsu Y; Tomonaga K
J Virol; 2021 Oct; 95(21):e0093621. PubMed ID: 34406860
[TBL] [Abstract][Full Text] [Related]
2. Splicing-Dependent Subcellular Targeting of Borna Disease Virus Nucleoprotein Isoforms.
Kojima S; Sato R; Yanai M; Komatsu Y; Horie M; Igarashi M; Tomonaga K
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541858
[TBL] [Abstract][Full Text] [Related]
3. Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.
Sakai M; Fujita Y; Komorizono R; Kanda T; Komatsu Y; Noda T; Tomonaga K; Makino A
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268525
[TBL] [Abstract][Full Text] [Related]
4. Dual function of the nuclear export signal of the Borna disease virus nucleoprotein in nuclear export activity and binding to viral phosphoprotein.
Yanai M; Sakai M; Makino A; Tomonaga K
Virol J; 2017 Jul; 14(1):126. PubMed ID: 28693611
[TBL] [Abstract][Full Text] [Related]
5. Generation of a non-transmissive Borna disease virus vector lacking both matrix and glycoprotein genes.
Fujino K; Yamamoto Y; Daito T; Makino A; Honda T; Tomonaga K
Microbiol Immunol; 2017 Sep; 61(9):380-386. PubMed ID: 28776750
[TBL] [Abstract][Full Text] [Related]
6. Reverse genetics approaches of Borna disease virus: applications in development of viral vectors and preventive vaccines.
Komatsu Y; Tomonaga K
Curr Opin Virol; 2020 Oct; 44():42-48. PubMed ID: 32659515
[TBL] [Abstract][Full Text] [Related]
7. Stability of Borna disease virus-based episomal vector under physical and chemical stimulation.
Yanai M; Sakai M; Komorizono R; Makino A; Tomonaga K
Microbiol Immunol; 2022 Jan; 66(1):24-30. PubMed ID: 34617609
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infections.
Neumann B; Angstwurm K; Linker RA; Knoll G; Eidenschink L; Rubbenstroth D; Schlottau K; Beer M; Schreiner P; Soutschek E; Böhmer MM; Lampl BMJ; Pregler M; Scheiter A; Evert K; Zoubaa S; Riemenschneider MJ; Asbach B; Gessner A; Niller HH; Schmidt B; Bauswein M
Cell Rep Med; 2022 Jan; 3(1):100499. PubMed ID: 35106511
[TBL] [Abstract][Full Text] [Related]
9. Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.
Yamamoto Y; Tomonaga K; Honda T
Front Microbiol; 2019; 10():2485. PubMed ID: 31781052
[TBL] [Abstract][Full Text] [Related]
10. Exogenous expression of both matrix protein and glycoprotein facilitates infectious viral particle production of Borna disease virus 1.
Kanda T; Sakai M; Makino A; Tomonaga K
J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35819821
[TBL] [Abstract][Full Text] [Related]
11. ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
Yanai M; Kojima S; Sakai M; Komorizono R; Tomonaga K; Makino A
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852792
[TBL] [Abstract][Full Text] [Related]
12. BUD23-TRMT112 interacts with the L protein of Borna disease virus and mediates the chromosomal tethering of viral ribonucleoproteins.
Garcia BCB; Horie M; Kojima S; Makino A; Tomonaga K
Microbiol Immunol; 2021 Nov; 65(11):492-504. PubMed ID: 34324219
[TBL] [Abstract][Full Text] [Related]
13. Borna disease virus phosphoprotein triggers the organization of viral inclusion bodies by liquid-liquid phase separation.
Hirai Y; Tomonaga K; Horie M
Int J Biol Macromol; 2021 Dec; 192():55-63. PubMed ID: 34606793
[TBL] [Abstract][Full Text] [Related]
14. Reverse Genetics and Artificial Replication Systems of Borna Disease Virus 1.
Kanda T; Tomonaga K
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298790
[TBL] [Abstract][Full Text] [Related]
15. Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein.
Schneider U; Naegele M; Staeheli P; Schwemmle M
J Virol; 2003 Nov; 77(21):11781-9. PubMed ID: 14557662
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary Selection of the Nuclear Localization Signal in the Viral Nucleoprotein Leads to Host Adaptation of the Genus
Komorizono R; Sassa Y; Horie M; Makino A; Tomonaga K
Viruses; 2020 Nov; 12(11):. PubMed ID: 33187187
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of favipiravir (T-705) against mammalian and avian bornaviruses.
Tokunaga T; Yamamoto Y; Sakai M; Tomonaga K; Honda T
Antiviral Res; 2017 Jul; 143():237-245. PubMed ID: 28465146
[TBL] [Abstract][Full Text] [Related]
18. Intracellular dynamics of actin affects Borna disease virus replication in the nucleus.
Hirai Y; Domae E; Yoshikawa Y; Okamura H; Makino A; Tomonaga K
Virus Res; 2019 Apr; 263():179-183. PubMed ID: 30769121
[TBL] [Abstract][Full Text] [Related]
19. Full-length genomic sequencing and characterization of Borna disease virus 1 isolates: Lessons in epidemiology.
Guo Y; He P; Sun L; Zhang X; Xu X; Tang T; Zhou W; Li Q; Zou D; Bode L; Xie P
J Med Virol; 2020 Dec; 92(12):3125-3137. PubMed ID: 32343416
[TBL] [Abstract][Full Text] [Related]
20. RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs.
Komatsu Y; Takeuchi D; Tokunaga T; Sakurai H; Makino A; Honda T; Ikeda Y; Tomonaga K
Mol Ther Methods Clin Dev; 2019 Sep; 14():47-55. PubMed ID: 31309127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
